Conquering Diseases

Study Of An Investigational Drug For Moderately To Severely Active Ulcerative Colitis

Description

Seeking people aged 16 and older with moderately to severely active ulcerative colitis that hasn't responded to treatment or stopped responding for a study of an investigational drug.

Overview

Participants in this study will be randomly assigned to get either one of two doses of the investigational drug or a placebo (looks like the drug but contains no medicine) to be taken once a day for 8 weeks. There are 5 study visits over the 16 week study. During the screening period participants will have a colonoscopy during which biopsies will be collected.

What we're hoping for

We are studying an investigational drug taken daily for moderately to severely active ulcerative colitis that has not responded to treatment or has stopped responding.

Additional Information

ClinicalTrials.gov Identifier: NCT05507216

 Principal Investigator

Abbas  Rupawala, MD

UMass Memorial Health

 Study Contact

Anne  Foley

Anne.foley@umassmemorial.org

 Location

UMass Chan University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989